This is routine check up
Reading File
Running Command
Here is a comprehensive review of Ms. Pallavi's routine check-up report (Age 40, Female | Collected: 19 May 2026 | Dr Lal PathLabs):
🔴 ABNORMAL FINDINGS — Needs Attention
1. Iron Deficiency Anemia (Most Significant Finding)
| Parameter | Result | Reference | Status |
|---|---|---|---|
| Hemoglobin | 11.90 g/dL | 12.00–15.00 | ⬇️ Low |
| PCV | 35.20% | 36–46% | ⬇️ Low |
| MCV | 79.10 fL | 83–101 fL | ⬇️ Low (microcytic) |
| MCH | 26.70 pg | 27–32 pg | ⬇️ Low |
| RDW | 15.30% | 11.60–14.00% | ⬆️ High |
| Serum Iron | 34.50 µg/dL | 50–170 µg/dL | ⬇️ Very low |
| TIBC | 429.80 µg/dL | 250–425 µg/dL | ⬆️ High |
| Transferrin Saturation | 8.03% | 15–50% | ⬇️ Very low |
| Mentzer Index | 17.7 | >13 → IDA | ✅ Consistent with IDA |
Interpretation: Classic iron deficiency anemia — low Hb, microcytic (low MCV), low iron, elevated TIBC, very low transferrin saturation, and high RDW. The Mentzer Index of 17.7 (>13) supports Iron Deficiency Anemia over beta-thalassemia trait.
Action: Iron supplementation (oral ferrous sulfate/ferrous ascorbate) is indicated. The referring doctor should investigate the cause of iron deficiency (dietary, menstrual losses, GI bleeding, malabsorption).
2. Liver Enzymes — Mildly Elevated
| Parameter | Result | Reference | Status |
|---|---|---|---|
| AST (SGOT) | 44.3 U/L | <35 U/L | ⬆️ High |
| ALT (SGPT) | 51.7 U/L | <35 U/L | ⬆️ High |
| GGTP | 39.2 U/L | <38 U/L | ⬆️ Marginally high |
| Bilirubin Total | 1.41 mg/dL | 0.30–1.20 | ⬆️ High |
| Bilirubin Direct | 0.25 mg/dL | <0.20 | ⬆️ Slightly high |
| Bilirubin Indirect | 1.16 mg/dL | <1.10 | ⬆️ Slightly high |
Interpretation: Mild transaminitis (AST+ALT both ~1.3–1.5× upper limit). AST:ALT ratio of 0.86 (<1) suggests a hepatocellular rather than alcoholic pattern. Could be early NAFLD (non-alcoholic fatty liver disease), medication effect, or related to the underlying iron deficiency. Globulin is also mildly elevated (4.04 vs. 2.0–3.5 g/dL) which may suggest chronic inflammation.
Action: Clinical correlation, consider hepatitis B/C serology, liver ultrasound if not recently done. Repeat LFTs in 4–6 weeks.
3. Lipid Profile — Elevated LDL
| Parameter | Result | Reference | Status |
|---|---|---|---|
| Total Cholesterol | 205 mg/dL | <200 | ⬆️ Borderline high |
| LDL Cholesterol | 134.2 mg/dL | <100 | ⬆️ High |
| Non-HDL Cholesterol | 152 mg/dL | <130 | ⬆️ High |
| HDL | 52.9 mg/dL | >50 | ✅ Normal |
| Triglycerides | 89.5 mg/dL | <150 | ✅ Normal |
Interpretation: LDL is significantly above the <100 mg/dL target. As per Lipid Association of India 2020, if she is in the moderate risk category (no known CVD/diabetes), goal is LDL <100 mg/dL and non-HDL <130 mg/dL. She currently exceeds both targets.
Action: Lifestyle intervention first — low saturated fat diet, increased physical activity. If no improvement after 3 months, pharmacological therapy (statin) may be warranted.
4. Serum Amylase — Mildly Elevated
| Parameter | Result | Reference | Status |
|---|---|---|---|
| Amylase | 101 U/L | 28–100 U/L | ⬆️ Marginally high |
Interpretation: Just 1 unit above the upper limit. Mildly elevated amylase can occur with minor salivary gland irritation, gastroenteritis, or medications. Acute pancreatitis typically shows values >3× ULN.
Action: Clinical correlation. If no abdominal symptoms, likely not significant. Repeat if symptoms develop.
5. hsCRP — Average Cardiovascular Risk
| Parameter | Result | Reference | Status |
|---|---|---|---|
| hsCRP | 1.64 mg/L | <1.00 | ⬆️ Average risk zone (1–3) |
Interpretation: Falls in the "average" cardiovascular risk zone (1–3 mg/L). Likely related to the underlying anemia/inflammation. Not alarming but should be monitored alongside the lipid findings.
6. Urine — Possible Early UTI
| Parameter | Result | Reference | Status |
|---|---|---|---|
| Leucocyte Esterase | 1+ (25 WBC/µL) | Negative | ⬆️ Positive |
| Pus Cells | 6–8 WBC/HPF | 0–5 | ⬆️ High |
| Protein | Traces | Negative | ⬆️ Trace |
| Nitrite | Negative | Negative | ✅ Normal |
Interpretation: Elevated pus cells with positive leucocyte esterase suggests asymptomatic bacteriuria or a mild UTI, though nitrite is negative. This can occur with contamination in women or early infection.
Action: If Ms. Pallavi has urinary symptoms (burning, frequency), a urine culture (C&S) should be ordered. If asymptomatic, repeat urinalysis after proper mid-stream collection.
✅ NORMAL / REASSURING FINDINGS
| Parameter | Result | Status |
|---|---|---|
| Kidney function (Creatinine, Urea, Uric Acid) | All normal | ✅ |
| eGFR | 114 mL/min/1.73m² (G1 — Optimal) | ✅ |
| Fasting Glucose | 81.3 mg/dL | ✅ |
| HbA1c | 5.1% | ✅ Non-diabetic |
| Thyroid (T3, T4, TSH) | All within normal range | ✅ |
| Vitamin D | 82.53 nmol/L (Sufficient >75) | ✅ |
| Vitamin B12 | 268 pg/mL (Normal) | ✅ |
| Calcium, Phosphorus, Electrolytes | All normal | ✅ |
| Apolipoproteins A1 & B, ApoB/ApoA1 ratio | All within normal range | ✅ |
| WBC count & differential | Normal | ✅ |
| Platelet count | 263 thou/mm³ | ✅ |
| ESR | 19 mm/hr | ✅ |
Summary & Priority Actions for Dr. Pravesh Gupta
- Iron Deficiency Anemia → Start iron supplementation; investigate underlying cause (menstrual history, dietary intake, GI bleeding)
- Mild Transaminitis → Hepatitis serology, consider liver ultrasound; repeat LFTs in 4–6 weeks
- Elevated LDL → Dietary modifications first; reassess lipid profile in 3 months
- Urine findings → Rule out UTI, repeat urinalysis with proper sample collection
- Amylase & hsCRP → Mildly elevated; clinical correlation needed; no immediate action if asymptomatic
⚠️ This is an AI-assisted interpretation for informational purposes. All clinical decisions must be made by the referring physician (Dr. Pravesh Gupta) in the context of the patient's full clinical history.
This is a shared conversation. Sign in to Orris to start your own chat.